TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15351753

Group type: COMPARATOR
Intervention: Peer leader education
Number of subjects: 638

Group type: COMPARATOR
Intervention: Planned care (nurse-mediated organizational change + peer leader education)
Number of subjects: 638
Study: 11607890

Group type: EXPERIMENTAL
Intervention: Transdermal oestradiol (Group 1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Transdermal oestradiol + vaginal progesterone (Group 2)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral oestradiol + vaginal progesterone (Group 3)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group without therapy (Group 4)
Number of subjects: 24
Study: 9675656

Group type: EXPERIMENTAL
Intervention: 6 million units of natural human fibroblast beta interferon three times a week for 12 months
Number of subjects: 92

Group type: COMPARATOR
Intervention: 3 million units of natural human fibroblast beta interferon three times a week for 12 months
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 6 million units of natural human fibroblast beta interferon
Number of subjects: 92
Study: 8032838

Group type: EXPERIMENTAL
Intervention: Clean intermittent catheterization (CIC) weekly for 1 year
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no CIC)
Number of subjects: 43
Study: 1922166

Group type: EXPERIMENTAL
Intervention: L-carnitine (1 g/orally b.i.d.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 6763836

Group type: EXPERIMENTAL
Intervention: Behavioural treatment programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardiological measures (e.g. diet, exercise, adherence to medication)
Number of subjects: 0
Study: 31302644

Group type: EXPERIMENTAL
Intervention: Sham opioid infusion (saline solution)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Nocebo conditioning (increased experimental pain)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Natural history (control group)
Number of subjects: 73
Study: 27550386

Group type: EXPERIMENTAL
Intervention: Dapagliflozin/exenatide
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 25720388

Group type: EXPERIMENTAL
Intervention: Subcutaneous exenatide for 11 days
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Intravenous exenatide
Number of subjects: 68

Group type: COMPARATOR
Intervention: Exendin-9 (GLP-1R antagonist)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Exenatide (ex vivo on human subcutaneous adipose tissue arterioles)
Number of subjects: 68

Group type: COMPARATOR
Intervention: AMPK inhibition
Number of subjects: 68
Study: 24494281

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 60
Study: 21178639

Group type: EXPERIMENTAL
Intervention: LDCT arm
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 100
Study: 19809230

Group type: EXPERIMENTAL
Intervention: Subacromial injection of 9 ml bupivacaine and 1 ml betamethasone
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no injection)
Number of subjects: 56
Study: 17520986

Group type: EXPERIMENTAL
Intervention: Intranasal sufentanil (2 microg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral midazolam (0.5 mg/kg in cherry juice)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral tramadol (3 mg/kg drops)
Number of subjects: 60
Study: 15567986

Group type: EXPERIMENTAL
Intervention: Recombinant HBV vaccine (20 microg doses at months 0, 1, and 6)
Number of subjects: 321
Study: 12368393

Group type: EXPERIMENTAL
Intervention: 3 g FOS + 80 mg cornstarch
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 3 g sucrose + 1 x 10(9) cfu LAC
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 3 g FOS + 1 x 10(9) cfu LAC
Number of subjects: 68

Group type: COMPARATOR
Intervention: 3 g sucrose + 80 mg cornstarch
Number of subjects: 68
Study: 9700882

Group type: EXPERIMENTAL
Intervention: Immunocorrective therapy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Chronic bacterial prostatitis
Number of subjects: 57
Study: 7985753

Group type: EXPERIMENTAL
Intervention: Malaria sporozoite vaccine (R32NS1(81))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (11 volunteers)
Number of subjects: 12
Study: 3134815

Group type: EXPERIMENTAL
Intervention: Tocolysis
Number of subjects: 109

Group type: COMPARATOR
Intervention: Bed rest
Number of subjects: 109
Study: 30926654

Group type: EXPERIMENTAL
Intervention: Gastric cancer risk prediction rule (based on age, sex, PG I/II ratio, G-17 level, H. pylori infection, pickled food, fried food)
Number of subjects: 14929

Group type: EXPERIMENTAL
Intervention: Gastroscopy for individuals with medium risk and high risk
Number of subjects: 14929

Group type: EXPERIMENTAL
Intervention: Prediction rule
Number of subjects: 14929
Study: 29292492

Group type: EXPERIMENTAL
Intervention: Blunt perforation of the ligamentum flavum (n=22)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cutting of the ligamentum flavum (n=28)
Number of subjects: 50
Study: 25169728

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) plus methotrexate (MTX)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 556
Study: 25188398

Group type: EXPERIMENTAL
Intervention: Internet-based support program (EDINA) over 4 months
Number of subjects: 105

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) control condition over 4 months
Number of subjects: 105
Study: 21214718

Group type: EXPERIMENTAL
Intervention: 6-month intervention program (cycle ergometer training twice a day for 5 days a week and a hypocaloric diet)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control program (unchanged pharmacologic therapy without exercise and diet)
Number of subjects: 88
Study: 18082776

Group type: EXPERIMENTAL
Intervention: Ultrasound arm
Number of subjects: 93

Group type: COMPARATOR
Intervention: Conventional arm
Number of subjects: 93
Study: 16942453

Group type: EXPERIMENTAL
Intervention: Supervised aerobic and resistance exercise program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Unsupervised walking program
Number of subjects: 40
Study: 12924169

Group type: EXPERIMENTAL
Intervention: trandolapril (T)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: felodipine ER (F)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: rilmenidine (R)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 39
Study: 11234653

Group type: EXPERIMENTAL
Intervention: Multivitamin-mineral combination (Berocca Calmag)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 9200196

Group type: EXPERIMENTAL
Intervention: All‐Bond 2/Bis‐Fil P, Unetched dentin, dry dentin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All‐Bond 2/Bis‐Fil P, Unetched dentin, moist dentin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All‐Bond 2/Bis‐Fil P, Dentin etched for 15 sec with 10% phosphoric acid, dry dentin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All‐Bond 2/Bis‐Fil P, Dentin etched for 15 sec with 10% phosphoric acid, moist dentin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐Purpose/Z100, Dentin etched with 10% maleic acid for 15 sec, dry dentin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐Purpose/Z100, Dentin etched with 10% maleic acid for 15 sec, moist dentin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Amalgambond Plus/Z100, Dentin etched with 10 citric acid/3% ferric chloride, dry dentin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Amalgambond Plus/Z100, Dentin etched with 10 citric acid/3% ferric chloride, moist dentin
Number of subjects: 40
Study: 1312506

Group type: EXPERIMENTAL
Intervention: Itraconazole (2 x 100 mg capsules taken twice in 24 hours)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Clotrimazole (500 mg vaginal tablet)
Number of subjects: 214
Study: 3838625

Group type: EXPERIMENTAL
Intervention: Operation with tourniquet
Number of subjects: 19

Group type: COMPARATOR
Intervention: Operation without tourniquet
Number of subjects: 19
Study: 31870634

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg daily for 26 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 26 weeks
Number of subjects: 60
Study: 30052994

Group type: EXPERIMENTAL
Intervention: Conservative surgery (shaving or disc excision)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Radical rectal surgery (segmental resection)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Natural conception
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overall pregnancies recorded
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Postoperative pregnancy rate in infertile patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Advice on natural conception vs ART
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probabilities of achieving pregnancy at various months postoperatively
Number of subjects: 60
Study: 26738641

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET) and strengths-based case management (SBCM)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Brief feedback (BF)
Number of subjects: 29
Study: 24581525

Group type: EXPERIMENTAL
Intervention: Wash method of specimen preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Swipe method of specimen preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of malignancy in biopsy specimen
Number of subjects: 0
Study: 22041501

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 20066400

Group type: EXPERIMENTAL
Intervention: Ketamine alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketamine + Nicotine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17661853

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg QD
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg BID
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1139
Study: 16051882

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 23

Group type: COMPARATOR
Intervention: Disulfiram (ALDH2 inhibition)
Number of subjects: 23
Study: 12113144

Group type: EXPERIMENTAL
Intervention: Continuity of care model
Number of subjects: 0
Study: 10404451

Group type: EXPERIMENTAL
Intervention: Amikacin 15 mg/kg once daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amikacin 7.5 mg/kg twice daily
Number of subjects: 40
Study: 7481640

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 70
Study: 2225374

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study: 6798382

Group type: EXPERIMENTAL
Intervention: Briserin (Reserpine, Clopamide, Dihydroergocristine)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Reserpine/Clopamide
Number of subjects: 40
Study: 31634025

Group type: EXPERIMENTAL
Intervention: IIV4-HD by intramuscular injection
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: IIV4-HD by subcutaneous injection
Number of subjects: 175

Group type: COMPARATOR
Intervention: IIV4-SD by subcutaneous injection
Number of subjects: 175
Study: 31158245

Group type: EXPERIMENTAL
Intervention: Modified directly-observed treatment (mDOT) with ledipasvir-sofosbuvir daily for 8 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Unobserved treatment with ledipasvir-sofosbuvir daily for 8 weeks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both mDOT and unobserved treatment
Number of subjects: 31
Study: 27664002

Group type: EXPERIMENTAL
Intervention: Stop/reduce vasoactive therapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Continue vasoactive therapy
Number of subjects: 58
Study: 26456895

Group type: EXPERIMENTAL
Intervention: Problem-solving intervention
Number of subjects: 173

Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 173
Study: 23725521

Group type: EXPERIMENTAL
Intervention: Lifestyle modification program (LMP) consisting of two individual and six group sessions over a nine month period.
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Lifestyle modification program (LMP) attendance predictors.
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Qualitative factors influencing attendance at the LMP.
Number of subjects: 197
Study: 21057005

Group type: EXPERIMENTAL
Intervention: IMA-638
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: IMA-026
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 19682111

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (higher-dose)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Subjects with depression
Number of subjects: 313

Group type: COMPARATOR
Intervention: Subjects without depression (control)
Number of subjects: 313
Study: 17442364

Group type: EXPERIMENTAL
Intervention: Retinotopic motion signals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smooth pursuit (stationary retinal image)
Number of subjects: 0
Study: 15045594

Group type: EXPERIMENTAL
Intervention: Transdermal GTN (10 mg per day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12385454

Group type: EXPERIMENTAL
Intervention: UDCA
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 9829367

Group type: EXPERIMENTAL
Intervention: AO-128 (2 mg three times daily)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 7656624

Group type: EXPERIMENTAL
Intervention: Albuterol (two puffs four times a day for 7 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Ipratropium (two puffs four times a day for 7 days)
Number of subjects: 15
Study: 2719503

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 12563

Group type: EXPERIMENTAL
Intervention: 100 mg tolamolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 20 mg bufuralol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous 10 mg tolamolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous 5 mg bufuralol
Number of subjects: 10
Study: 31884303

Group type: EXPERIMENTAL
Intervention: hiPEM (high post-exertional malaise)
Number of subjects: 261

Group type: COMPARATOR
Intervention: loPEM (low post-exertional malaise)
Number of subjects: 261
Study: 31008935

Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil (group PR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Propofol-midazolam-remifentanil (group PMR)
Number of subjects: 120
Study: 28777828

Group type: EXPERIMENTAL
Intervention: Smartphone Addiction Inventory (SPAI) Scale
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Depression and anxiety scores
Number of subjects: 688

Group type: COMPARATOR
Intervention: Demographic and lifestyle factors (gender, residence, work hours, faculty, GPA, smoking, alcohol drinking, religious practice)
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Personality type A, younger age at first smartphone use, excessive use during a weekday, using smartphone for entertainment, not using it to call family members
Number of subjects: 688
Study: 27376418

Group type: EXPERIMENTAL
Intervention: Sprint exercise (five × ten‐second cycle sprints)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Aggressive video clip
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 26
Study: 23766483

Group type: EXPERIMENTAL
Intervention: Home based HIV counselling and testing
Number of subjects: 4154

Group type: COMPARATOR
Intervention: Control (standard care at local clinics)
Number of subjects: 4154
Study: 21839414

Group type: EXPERIMENTAL
Intervention: Four cycles of anthracycline followed by docetaxel (ACD)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Four cycles of anthracycline followed by paclitaxel (ACP)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Eight cycles of docetaxel (DTX)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Eight cycles of paclitaxel (PTX)
Number of subjects: 300
Study: 19810001

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16722155

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation with face mask (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conservative medical therapy (oxygen, bronchodilator, corticosteroid) (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conservative medical therapy (Group A)
Number of subjects: 60
Study: 15231444

Group type: EXPERIMENTAL
Intervention: Citalopram (n = 19)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Sertraline (n = 18)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 58
Study: 11071485

Group type: EXPERIMENTAL
Intervention: Brains with IGE
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control brains
Number of subjects: 10
Study: 9282303

Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (DA3177) at a daily dose of 75 mg t.i.d. (Group D)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Scopolamine butylbromide at a daily dose of 60 mg t.i.d. (Group B)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (DA3177) (Group D)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Scopolamine butylbromide (Group B)
Number of subjects: 198
Study: 8344816

Group type: EXPERIMENTAL
Intervention: HyperLung (multimedia textbook)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Lecture (standard lecture)
Number of subjects: 49
Study: 3028457

Group type: EXPERIMENTAL
Intervention: 5 mg enalapril orally
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29914530

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (6 g)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 39
Study: 27027897

Group type: EXPERIMENTAL
Intervention: Non-linear resistance training (NLRT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study: 24190895

Group type: EXPERIMENTAL
Intervention: RSV activity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Seasonal variations in carriage prevalence
Number of subjects: 0
Study: 23113928

Group type: EXPERIMENTAL
Intervention: Dual-task gait training
Number of subjects: 44

Group type: COMPARATOR
Intervention: Single-task gait training
Number of subjects: 44
Study: 20860598

Group type: EXPERIMENTAL
Intervention: Medical termination of pregnancy (MTOP) using mifepristone and misoprostol
Number of subjects: 122

Group type: COMPARATOR
Intervention: Surgical termination of pregnancy (STOP) by vacuum aspiration or dilatation and evacuation
Number of subjects: 122
Study: 18660469

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 204
Study: 16169328

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 25
Study: 12534645

Group type: EXPERIMENTAL
Intervention: Ketoconazole 200 mg twice daily for 7 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 11011325

Group type: EXPERIMENTAL
Intervention: DDDR pacemaker programmed to VVIR or DDDR
Number of subjects: 2010
Study: 8974970

Group type: EXPERIMENTAL
Intervention: Crataegus-Specialextract WS 1442
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 1642224

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aspirin, Naproxen, Placebo
Number of subjects: 90
Study: 6420340

Group type: EXPERIMENTAL
Intervention: Enteral nutrition via tube feeding into the first part of the jejunum
Number of subjects: 20

Group type: COMPARATOR
Intervention: Parenteral nutrition via central venous catheter
Number of subjects: 20
Study: 31878000

Group type: EXPERIMENTAL
Intervention: Vegans
Number of subjects: 72

Group type: COMPARATOR
Intervention: Omnivores
Number of subjects: 72
Study: 29389015

Group type: EXPERIMENTAL
Intervention: Foster care
Number of subjects: 147

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Foster care (before age 20 months)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Foster care (after age 20 months)
Number of subjects: 147
Study: 26803764

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 129

Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 129
Study: 27128837

Group type: EXPERIMENTAL
Intervention: GSK961081 800 µg and FP 500 µg as a blend formulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: GSK961081 800 µg and FP 500 µg concurrently via separate inhalers
Number of subjects: 24

Group type: COMPARATOR
Intervention: FP 500 µg alone
Number of subjects: 24
Study: 22634355

Group type: EXPERIMENTAL
Intervention: New threatening information about half of the learned objects
Number of subjects: 81

Group type: COMPARATOR
Intervention: New neutral information about half of the learned objects
Number of subjects: 81
Study: 20520031

Group type: EXPERIMENTAL
Intervention: High-fidelity training
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Progressive training (low to mid to high fidelity)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Low-fidelity training
Number of subjects: 45
Study: 19198268

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Ozonotherapy (intravenous infusion of ozonized physiological solution)
Number of subjects: 118
Study: 15637467

Group type: EXPERIMENTAL
Intervention: Cyanotic CHD
Number of subjects: 56

Group type: COMPARATOR
Intervention: Acyanotic CHD
Number of subjects: 56
Study: 12682081

Group type: EXPERIMENTAL
Intervention: Fasudil (3, 10, and 30 microg/min for 5 minutes)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sodium nitroprusside (0.75, 1.5, and 3.0 microg/min for 5 minutes)
Number of subjects: 16